Circulating isoprostanes: Gate keepers in the route from oxidative stress to vascular dysfunction

Circulation Research

Volumn 103, Issue 9, 2008, Pages 907-909

  Sauer, Heinrich ^a   Wartenberg, Maria ^b  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Angiogenesis; Oxidant signaling; Oxidative stress; Thromboxane

Indexed keywords

FIBROBLAST GROWTH FACTOR; ISOPROSTANE DERIVATIVE; NITRIC OXIDE; PLATELET DERIVED GROWTH FACTOR; PROSTAGLANDIN H2; PROSTAGLANDIN SYNTHASE; PROTEIN TYROSINE PHOSPHATASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; THROMBOXANE A2; VASCULOTROPIN; ANGIOGENESIS INHIBITOR; THROMBOXANE A2 RECEPTOR; VASCULOTROPIN A;

CARDIOVASCULAR DISEASE; CELL MOTILITY; EDITORIAL; HEART FUNCTION; HUMAN; LIPID PEROXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; VASCULAR DISEASE; VASOCONSTRICTION; ANGIOGENESIS; ANIMAL; CELL MOTION; DRUG EFFECT; ENDOTHELIUM CELL; GENETICS; METABOLISM; NOTE; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION;

ANGIOGENESIS INHIBITORS; ANIMALS; CELL MOVEMENT; ENDOTHELIAL CELLS; HUMANS; ISOPROSTANES; NEOVASCULARIZATION, PHYSIOLOGIC; OXIDATIVE STRESS; RECEPTORS, THROMBOXANE A2, PROSTAGLANDIN H2; SIGNAL TRANSDUCTION; VASCULAR DISEASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 55449109210     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.108.187278     Document Type: Editorial

References (19)

1. Feletou M, Tang EH, Vanhoutte PM. Nitric oxide the gatekeeper of endothelial vasomotor control. Front Biosci. 2008;13:4198-4217.
2. Montuschi P, Barnes P, Roberts LJ. Insights into oxidative stress: the isoprostanes. Curr Med Chem. 2007;14:703-717.
3. Musiek ES, McLaughlin B, Morrow JD. Electrophilic cyclopentenone isoprostanes in neurodegeneration. J Mol Neurosci. 2007;33:80-86.
4. Morrow JD, Hill KE, Burk RF, Nammour TM, Badr KF, Roberts LJ. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci U S A. 1990;87:9383-9387.
5. Morrow JD, Harris TM, Roberts LJ. Noncyclooxygenase oxidative formation of a series of novel prostaglandins: analytical ramifications for measurement of eicosanoids. Anal Biochem. 1990;184:1-10.
6. Comporti M, Signorini C, Arezzini B, Vecchio D, Monaco B, Gardi C. F2-isoprostanes are not just markers of oxidative stress. Free Radic Biol Med. 2008;44:247-256.
7. Kadiiska MB, Gladen BC, Baird DD, Germolec D, Graham LB, Parker CE, Nyska A, Wachsman JT, Ames BN, Basu S, Brot N, Fitzgerald GA, Floyd RA, George M, Heinecke JW, Hatch GE, Hensley K, Lawson JA, Marnett LJ, Morrow JD, Murray DM, Plastaras J, Roberts LJ, Rokach J, Shigenaga MK, Sohal RS, Sun J, Tice RR, Van Thiel DH, Wellner D, Walter PB, Tomer KB, Mason RP, Barrett JC. Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radic Biol Med. 2005;38:698-710.
8. Khasawneh FT, Huang JS, Mir F, Srinivasan S, Tiruppathi C, Le Breton GC. Characterization of isoprostane signaling: evidence for a unique coordination profile of 8-iso-PGF(2alpha) with the thromboxane A(2) receptor, and activation of a separate cAMP-dependent inhibitory pathway in human platelets. Biochem Pharmacol. 2008;75:2301-2315.
9. Benndorf RA, Schwedhelm E, Gnann A, Taheri R, Kom G, Didie M, Steenpass A, Ergün S, Boger RH. Isoprostanes inhibit vascular endothelial growth factor-induced endothelial cell migration, tube formation, and cardiac vessel sprouting in vitro, as well as angiogenesis in vivo via activation of the thromboxane A2 receptor. A potential link between oxidative stress and impaired angiogenesis. Circ Res. 2008;103: 1037-1046.
10. Goswami SK, Maulik N, Das DK. Ischemia-reperfusion and cardiopro-tection: a delicate balance between reactive oxygen species generation and redox homeostasis. Ann Med. 2007;39:275-289.
11. Ushio-Fukai M. Redox signaling in angiogenesis: role of NADPH oxidase. Cardiovasc Res. 2006;71:226-235.
12. Lange S, Heger J, Euler G, Wartenberg M, Piper HM, Sauer H. PDGF-BB stimulates vasculogenesis of embryonic stem cell-derived endothelial cells by calcium-mediated generation of reactive oxygen species. Cardiovasc Res. In press.
13. Black SM, DeVol JM, Wedgwood S. Regulation of fibroblast growth factor-2 expression in pulmonary arterial smooth muscle cells involves increased reactive oxygen species generation. Am J Physiol Cell Physiol. 2008;294:C345-C354.
14. Frey RS, Ushio-Fukai M, Malik A. NADPH oxidase-dependent signaling in endothelial cells: role in physiology and pathophysiology. Antioxid Redox Signal. In press.
15. Simmons DL, Botting RM, Hla T. Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev. 2004;56: 387-437.
16. Mueed I, Tazzeo T, Liu C, Pertens E, Zhang Y, Cybulski I, Semelhago L, Noora J, Lamy A, Teoh K, Chu V, Janssen LJ. Isoprostanes constrict human radial artery by stimulation of thromboxane receptors, Ca2 + release, and RhoA activation. J Thorac Cardiovasc Surg. 2008;135: 131-138.
17. Ashton AW, Ware JA. Thromboxane A2 receptor signaling inhibits vascular endothelial growth factor-induced endothelial cell differentiation and migration. Circ Res. 2004;95:372-379.
18. Graupera M, Guillermet-Guibert J, Foukas LC, Phng LK, Cain RJ, Salpekar A, Pearce W, Meek S, Millan J, Cutillas PR, Smith AJ, Ridley AJ, Ruhrberg C, Gerhardt H, Vanhaesebroeck B. Angiogenesis selectively requires the p110alpha isoform of PI3K to control endothelial cell migration. Nature. 2008;453:662-666.
19. Wikstrom K, Kavanagh DJ, Reid HM, Kinsella BT. Differential regulation of RhoA-mediated signaling by the TPalpha and TPbeta isoforms of the human thromboxane A2 receptor: independent modulation of TPalpha signaling by prostacyclin and nitric oxide. Cell Signal. 2008;20:1497-1512.